Latest in 2024, Sotolaxib has become the new favorite of medicine!

Sotorasib is a new generation of targeted anti-cancer drugs, which belongs to the category of small molecule targeted drugs. Its unique mechanism of action mainly focuses on cancer treatment related to KRAS gene mutations, and KRAS mutations are very common in many cancer types, such as non-small cell lung cancer (NSCLC).

The KRAS gene is a key gene that regulates cell growth and differentiation. When mutated, it can lead to uncontrolled cell growth and the formation of cancer. In the past, due to the complexity of KRAS gene mutations, it has long been a difficulty in cancer research, and the advent of sotorasiib has filled the gap in this field.

Sotorasiib is unique in its ability to specifically inhibit the KRAS G12C mutation, a common KRAS mutation subtype. By binding to the mutated KRAS gene, sotoraxib can effectively block abnormal cell signaling pathways, thereby inhibiting the growth and spread of cancer cells.

In addition, clinical trial data of sotoraxib shows that it has achieved significant efficacy in the treatment of KRAS G12Cmutated non-small cell lung cancer, providing a new treatment option for patients who have previously been difficult to effectively treat. This innovative drug brings hope to the field of tumor treatment and has attracted widespread attention in the medical community.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.